Works matching IS 03407004 AND DT 2025 AND VI 74 AND IP 1
Results: 40
Q11, a CYP2E1 inhibitor, exerts anti-hepatocellular carcinoma effect by inhibiting M2 macrophage polarization.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03912-1
- By:
- Publication type:
- Article
Targeting OAS3 for reversing M2d infiltration and restoring anti-tumor immunity in pancreatic cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03898-w
- By:
- Publication type:
- Article
Targeting OAS3 for reversing M2d infiltration and restoring anti-tumor immunity in pancreatic cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03898-w
- By:
- Publication type:
- Article
Intratumoural CD8<sup>+</sup> CXCR5<sup>+</sup> follicular cytotoxic T cells have prognostic value and are associated with CD19<sup>+</sup> CD38<sup>+</sup> B cells and tertiary lymphoid structures in colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03887-z
- By:
- Publication type:
- Article
Intratumoural CD8<sup>+</sup> CXCR5<sup>+</sup> follicular cytotoxic T cells have prognostic value and are associated with CD19<sup>+</sup> CD38<sup>+</sup> B cells and tertiary lymphoid structures in colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03887-z
- By:
- Publication type:
- Article
Correction: The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Integrated multi-omics analysis reveals clinical significance of hepatocyte nuclear factor-1β in tumor immune microenvironment, immunotherapy and prognostic prediction for colon adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03870-8
- By:
- Publication type:
- Article
COVID-19–sensitive tumour response: 2-year assessment of the SARS-CoV-2 humoral response in cancer patients in oncology hospital in Poland.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03895-z
- By:
- Publication type:
- Article
Artificial neural network systems to predict the response to sintilimab in squamous-cell non-small-cell lung cancer based on data of ORIENT-3 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03886-0
- By:
- Publication type:
- Article
HLA-G high-expressor 3’UTR markers are linked to gastric cancer development and survival.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03771-w
- By:
- Publication type:
- Article
Immunological differences between monophasic and biphasic synovial sarcoma with implications for immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03868-2
- By:
- Publication type:
- Article
Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03839-7
- By:
- Publication type:
- Article
Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03872-6
- By:
- Publication type:
- Article
Hepatitis associated with immune checkpoint inhibitors-based combinations of other therapies: A real-world pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03858-4
- By:
- Publication type:
- Article
Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03871-7
- By:
- Publication type:
- Article
Cryo-thermal therapy reshaped the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03884-2
- By:
- Publication type:
- Article
“Tumor immunology meets oncology” (TIMO), 18 April–20 April 2024, in Brandenburg an der Havel, Germany.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03877-1
- By:
- Publication type:
- Article
Overcoming immunosuppression in cancer: how ketogenic diets boost immune checkpoint blockade.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03867-3
- By:
- Publication type:
- Article
Periodontitis promotes tumor growth and immune evasion via PD-1/PD-L1.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03865-5
- By:
- Publication type:
- Article
Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03847-7
- By:
- Publication type:
- Article
NLRP12/C1qA positive feedback in tumor-associated macrophages regulates immunosuppression through LILRB4/NF-κB pathway in lung adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03880-6
- By:
- Publication type:
- Article
Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03855-7
- By:
- Publication type:
- Article
Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03853-9
- By:
- Publication type:
- Article
Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03857-5
- By:
- Publication type:
- Article
Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03849-5
- By:
- Publication type:
- Article
Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03869-1
- By:
- Publication type:
- Article
Spontaneous high clonal expansion of Wilms’ tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms’ tumor gene 1-expressing solid tumor.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03862-8
- By:
- Publication type:
- Article
Nicotine promotes M2 macrophage polarization through α5-nAChR/SOX2/CSF-1 axis in lung adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03866-4
- By:
- Publication type:
- Article
Combination of ataxia telangiectasia and Rad3-related inhibition with ablative radiotherapy remodels the tumor microenvironment and enhances immunotherapy response in lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03864-6
- By:
- Publication type:
- Article
New insights into the immunomodulatory potential of sialic acid on monocyte-derived dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03863-7
- By:
- Publication type:
- Article
Uncovering the role of tumor cGAS expression in predicting response to PD-1/L1 inhibitors in non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03861-9
- By:
- Publication type:
- Article
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03860-w
- By:
- Publication type:
- Article
Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03854-8
- By:
- Publication type:
- Article
Ly6E on tumor cells impairs anti-tumor T-cell responses: a novel mechanism of tumor-induced immune exclusion.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03851-x
- By:
- Publication type:
- Article
Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03850-y
- By:
- Publication type:
- Article
Differential T cell accumulation within intracranial and subcutaneous melanomas is associated with differences in intratumoral myeloid cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03832-0
- By:
- Publication type:
- Article
Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03817-z
- By:
- Publication type:
- Article
Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 1, p. 1, doi. 10.1007/s00262-024-03816-0
- By:
- Publication type:
- Article